Brief: Amniotics Q2 EBITDA Loss Narrows To SEK 10.2 Mln
Aug 16 (Reuters) - Amniotics AB (publ) AMNI.ST :
* REPORT FOR THE SECOND QUARTER 2022
* Q2 TOTAL REVENUES: SEK 0 (0).
* Q2 OPERATING LOSS (EBITDA): SEK 10.2 (LOSS 17.2) MILLION
Source text for Eikon: ID:nMFN2Rt62g
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan